What Is CPT Code 74183 for an MRI With Contrast?

CPT code 74183 is the medical billing code for a complete MRI of the abdomen performed first without contrast material, then again with intravenous contrast, followed by additional post-contrast image sequences. In practical terms, it describes the most thorough version of an abdominal MRI, where the radiologist captures a full set of baseline images of your organs before injecting a gadolinium-based contrast agent and then acquiring several more rounds of images as the dye circulates through your liver, kidneys, pancreas, and surrounding structures. This two-stage approach gives physicians more diagnostic information than either an unenhanced or contrast-only scan alone, which is why it tends to be the go-to code when a definitive answer about a suspicious mass or organ abnormality is needed.

How 74183 Differs From the Other Abdominal MRI Codes

Three CPT codes cover abdominal MRI, and the difference comes down to whether contrast is used and how many phases are acquired. Code 74181 covers an MRI of the abdomen without any contrast at all. Code 74182 covers an MRI with contrast only, meaning no pre-contrast baseline images are obtained. Code 74183, the “without contrast followed by with contrast” study, combines both and then adds further post-contrast sequences. Hospitals and insurance companies treat these as distinct procedures with different reimbursement levels, so using the wrong code can cause claim denials or unexpected bills.

In most clinical scenarios involving the liver, pancreas, kidneys, or adrenal glands, 74183 is the code that gets ordered. Pre-contrast images establish what the tissues look like at baseline, particularly on certain weighted sequences that reveal fat content, iron deposits, or hemorrhage. The contrast-enhanced images then show how blood flows through a lesion and how it behaves over time. Without that baseline comparison, the radiologist loses a layer of information that can change a diagnosis. A lesion that appears bright before contrast, for instance, tells a very different story than one that only lights up after the injection.

What Actually Happens During the Scan

An abdominal MRI coded as 74183 typically takes 30 to 45 minutes in the scanner, though the exact time varies by facility and the specific protocol being run. You lie on your back on the MRI table, and the technologist positions a surface coil over your abdomen to improve image quality. The first portion of the exam collects images without contrast, including sequences sensitive to water content, fat, and tissue characteristics. You will be asked to hold your breath repeatedly, usually for around 15 to 20 seconds at a time, because breathing motion blurs abdominal images.

After the pre-contrast sequences are finished, a nurse or technologist places an IV line (if one is not already in) and injects the gadolinium-based contrast agent. From this point, timing becomes critical. The scanner acquires images in rapid succession across multiple phases as the contrast moves through your bloodstream. In liver imaging, for example, the arterial phase captures the few seconds when contrast fills the hepatic arteries, the portal venous phase shows it flowing through the portal vein, and the delayed phase captures images several minutes later when contrast has distributed more evenly. Research on liver MRI protocols has shown that acquiring multiple rapid arterial-phase passes rather than a single one captures the peak enhancement window more reliably and improves the visibility of blood-vessel-rich lesions.¹ Each of those phases tells the radiologist something different about how a lesion takes up and washes out contrast, which is often the single most important clue to what the lesion actually is.

Preoperative abdominal MRI studies routinely include this full set of arterial, portal venous, and delayed phase images as the standard dynamic contrast protocol.² The breath-hold requirement during these phases is one reason the exam can feel demanding. Newer approaches to abdominal MRI are making these breath-holds shorter and more manageable. Some research groups have developed ultra-fast 3D imaging methods that can capture whole-liver scans within a single breath-hold, reducing the number of times you need to suspend breathing.³

Why Doctors Order the Complete Study

The main reason 74183 gets ordered rather than a simpler, contrast-free scan is that contrast behavior is often what makes or breaks a diagnosis. Many abdominal organs look similar on unenhanced MRI, and different pathologies can mimic each other. A benign hemangioma in the liver, for example, enhances in a slow, peripheral, “fill-in” pattern over time, while a malignant tumor tends to enhance rapidly in the arterial phase and wash out quickly. Without those dynamic contrast phases, the radiologist may not be able to tell the two apart.

This is especially true for liver lesions. When MRI with a liver-specific contrast agent was compared against contrast-enhanced ultrasound for distinguishing between certain benign liver tumors, the MRI approach reached a sensitivity and specificity of about 95% each, compared to 85% and 87% for ultrasound.⁴ Other comparative research on focal liver lesions has consistently found that while contrast-enhanced ultrasound can achieve high accuracy for certain tasks, MRI-based methods tend to show better sensitivity and lower false-negative rates overall.⁵

The code is also commonly ordered for evaluating pancreatic masses, kidney tumors, adrenal nodules, and abdominal staging of certain cancers. In patients with known kidney cancer, for instance, doctors use CT or MRI with contrast to assess whether suspicious pancreatic lesions represent metastatic disease or a separate tumor, looking at features like enhancement pattern, size, and location within the gland.⁶ In all of these scenarios, the combination of pre- and post-contrast images that 74183 describes is the standard of care because it provides the richest diagnostic information in a single sitting.

What the Gadolinium Contrast Agent Does

The contrast material used in abdominal MRI is a gadolinium-based compound injected into a vein in your arm. Gadolinium is a rare-earth metal that, when bound to a carrier molecule, alters the magnetic properties of nearby water molecules in your tissues, making certain structures appear much brighter on the images. Unlike the iodine-based contrast used in CT scans, gadolinium agents do not expose you to radiation, and they work through a completely different mechanism.

Several types of gadolinium agents exist, and the choice matters for abdominal imaging. Some are “extracellular” agents that distribute throughout the blood and the spaces between cells, then wash out through the kidneys relatively quickly. Others are “hepatobiliary” agents, meaning they are partially taken up by liver cells and excreted into bile, providing an additional delayed phase unique to the liver. This hepatobiliary phase, acquired about 20 minutes after injection, can help distinguish lesions that contain functioning liver cells from those that do not. Your radiologist or ordering physician chooses the agent based on the clinical question being asked.

Kidney Function and the Risk of Nephrogenic Systemic Fibrosis

The most discussed safety concern with gadolinium contrast is nephrogenic systemic fibrosis, a rare but serious condition affecting the skin, joints, and internal organs that was identified in patients with severe kidney disease who received certain older gadolinium agents. Because your kidneys are the main route for clearing gadolinium from the body, impaired kidney function means the agent lingers longer, and in the past, some of the less chemically stable formulations released free gadolinium ions that triggered fibrotic tissue changes. Guidelines now recommend screening for kidney disease before giving any gadolinium-based contrast.⁷

The reassuring news is that the newer, more chemically stable gadolinium agents (called macrocyclic or Group II agents) have an excellent safety record even in high-risk patients. A systematic review pooling data from over 4,900 patients with advanced kidney disease who received these newer agents found zero confirmed cases of nephrogenic systemic fibrosis, with the upper bound of the confidence interval sitting below one tenth of one percent.⁸ A large retrospective study of patients with advanced kidney disease or end-stage renal disease who received gadolinium confirmed these findings, showing no meaningful increase in fibrosis-related diagnoses compared to patients who did not receive contrast.⁹

That said, the historical cases were real and overwhelmingly involved patients on dialysis who received older linear gadolinium agents like gadodiamide or gadopentetate dimeglumine. A review of 173 cases found that the majority of affected patients were undergoing dialysis, and the time between gadolinium exposure and the onset of symptoms ranged from as few as two days to as long as three years.¹⁰ The practical upshot is that if you have healthy kidneys, your risk is essentially zero. If you have moderate to severe kidney disease, your imaging team will use a safer agent and may take additional precautions such as reducing the dose or scheduling dialysis afterward.

Gadolinium Deposition in the Brain and Body

A more recent concern, and one that generates a lot of anxiety when patients read about it online, involves the discovery that small amounts of gadolinium can deposit in certain brain structures and other tissues even in people with perfectly normal kidneys. Research over the past decade has documented concentration-dependent gadolinium deposition in the brain, particularly in the globus pallidus and the dentate nucleus of the cerebellum, visible as bright spots on certain MRI sequences in patients who have received multiple gadolinium doses over time.¹¹ Gadolinium has also been detected in tissues outside the brain, including liver, skin, and bone.

The type of gadolinium agent matters significantly here. Animal studies designed to mimic clinical conditions have shown that linear gadolinium agents leave residual gadolinium in brain tissue at concentrations roughly 50 times higher than macrocyclic agents, with the macrocyclic levels being comparable to control animals that never received any contrast at all.¹² This is one of the main reasons that many countries have restricted or withdrawn the linear agents for routine use, and why the macrocyclic agents have become the default in most radiology departments.

Whether these trace depositions cause any harm remains an open and actively studied question. No confirmed clinical effects have been linked to brain gadolinium deposition in people with normal kidney function as of the current evidence. Isolated case reports have described patients who report symptoms they attribute to gadolinium retention, including cases in individuals with connective tissue disorders who may clear gadolinium differently.¹³ For now, the medical consensus is that the diagnostic benefit of contrast-enhanced MRI outweighs the theoretical risk of deposition for the vast majority of patients, but this is an area where the science is still evolving. If you are someone who needs repeated MRIs over time and this concerns you, it is a reasonable topic to raise with your doctor.

Preparing for an Abdominal MRI With Contrast

Preparation requirements vary somewhat by facility and by the specific organ being evaluated, but some elements are standard. Most centers ask you to fast for four to six hours before an abdominal MRI, particularly if the liver or pancreas is the focus. Fasting reduces gallbladder contraction and bowel motion, both of which can degrade image quality. Some protocols also ask you to drink water shortly before the exam to fill the stomach and duodenum, creating a natural contrast that helps outline the pancreas and surrounding structures.

You will be asked about metal implants, pacemakers, cochlear implants, and any prior surgeries involving metallic hardware. Some older implants are not MRI-compatible, and the strong magnetic field can cause serious injury if an incompatible device is present. Most modern orthopedic hardware and many cardiac devices are now MRI-conditional, meaning they can safely go into the scanner under specific conditions, but this needs to be verified beforehand. You will also be asked about kidney disease, allergies to contrast agents, and pregnancy.

Claustrophobia is worth mentioning honestly to the scheduling staff when you book. Many facilities offer mild sedation for patients who cannot tolerate the enclosed bore of a standard MRI scanner, and some have wide-bore or open MRI systems that reduce the confined feeling, though these may produce slightly lower image quality for abdominal studies.

Cost and Insurance Considerations

The cost of an abdominal MRI billed under 74183 varies widely depending on whether you are at a hospital outpatient department, a freestanding imaging center, or an academic medical center. In the United States, the total charge can range from a few hundred dollars at an independent imaging center to several thousand dollars at a hospital facility, before insurance adjustments. The “facility fee” at hospitals tends to be the biggest variable. If you have a choice of imaging location and your doctor does not require a specific facility, calling around for pricing can save a significant amount of money.

Insurance plans generally cover 74183 when it is deemed medically necessary, which typically means your doctor has documented a clinical indication such as a suspicious finding on a prior scan, elevated liver enzymes with an unclear cause, cancer staging, or surveillance for a known condition. Prior authorization is required by many plans, and the imaging center usually handles this. If authorization is denied, the denial letter will usually reference whether the code itself was disputed or whether the insurer believes a less expensive study (like an ultrasound or a non-contrast MRI under 74181) would suffice. Understanding that 74183 is specifically the “with and without contrast” code can help you and your doctor appeal more effectively, because the appeal can focus on why the contrast component is clinically necessary for your particular situation.

One billing pitfall to watch for is “unbundling,” where the facility separately bills 74181 and 74182 instead of using the combined 74183 code. When the exam is performed as a single session with pre- and post-contrast sequences, 74183 is the correct code, and billing the two component codes separately inflates the charge. If you see both 74181 and 74182 on a bill for what was clearly one continuous exam, ask the billing department to correct it.

When a Simpler Code Might Be Enough

Not every abdominal MRI needs contrast. A non-contrast abdominal MRI (74181) is sometimes adequate for evaluating certain conditions. Quantifying liver fat content or measuring iron overload, for instance, relies on signal characteristics visible on unenhanced sequences and does not require gadolinium. Simple cyst characterization, where the lesion meets all the criteria for a benign cyst on non-contrast images, also may not need contrast phases. If your doctor orders 74181 and you were expecting the full contrast study, it does not necessarily mean you are getting an inferior exam. It may mean the clinical question can be answered without the contrast, sparing you the IV and the additional time in the scanner.

On the other end, some situations call for even more specialized MRI protocols that still fall under 74183 but involve additional sequences beyond the standard dynamic phases. MR enterography for inflammatory bowel disease, for example, includes the same pre- and post-contrast framework but adds sequences optimized for the small bowel. MRCP, or magnetic resonance cholangiopancreatography, images the bile ducts and pancreatic duct using heavily water-weighted sequences, and when performed alongside a full contrast study, the entire exam gets billed under 74183 with the MRCP sequences essentially rolled in. These protocol differences do not change the CPT code, but they do change what the radiologist can evaluate and how long you spend in the scanner.